BPG is committed to discovery and dissemination of knowledge
Evidence Review
Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 21, 2026; 32(47): 124712
Published online Dec 21, 2026. doi: 10.3748/wjg.124712
Table 3 Experimental studies and mechanisms of action of Astragalus and its active components in the chronic atrophic gastritis treatment
Research contents
Action targets
Outcomes
Ref.
Astragalus membranaceusH. pylori vacuolating cytotoxin AInhibition of H. pylori activityWang et al[58]
Inflammatory factorsSuppression of pro-inflammatory cytokines and immunomodulationLiu et al[60]
Th1/Th2 and Treg/Th17 immune axesEnhancing immune toleranceChang et al[63]
PI3K/Akt, Wnt/β-catenin, and Janus kinase-signal transducer and activator of transcription 3 pathwaysProtecting the gastric mucosaLiu et al[66]; Yan and Zhang[67]
Acetobacter and Escherichia coliAlleviating gut microbial metabolic disordersLiu[71]; Liu et al[72]
Astragaloside IVH. pylori urease and related genes (ureA, ureB)Attenuating the colonization ability of H. pyloriWang et al[59]
CXCL5-CXCR2 axis and the NF-κB pathwayAnti-inflammatory effects and inhibition of inflammation-to-cancer transformationPei et al[64]; Tian et al[65]
Thrombin/PAR-1, p53, and MAPK signaling pathwaysIncreasing gastric acid secretion and protecting the gastric mucosaShen et al[68]; Duan et al[69]
Bifidobacterium and the Wnt3a/β-catenin signaling pathwayRegulation of serum metabolite levels and anti-tumor effectsWen et al[73]
Reactive oxygen species, serum nitric oxide, and inducible nitric oxide synthaseAntioxidant and anticancer effects and improvement of clinical efficacy in CAGXia et al[75]; Li et al[76]
Astragalus polysaccharidesNF-κB p65/MAPK signaling pathwayEnhancement of immunomodulatory effectsFeng et al[62]
Epidermal growth factor receptor downstream effector proteins cyclooxygenase-2 and metalloproteinases-2Protection of the gastric mucosaZhu et al[70]
Total astragalosidesImmune factorsEnhancement of immunomodulatory capacityZhang et al[61]


Write to the Help Desk